Nazione: Canada
Lingua: inglese
Fonte: Health Canada
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3
AVENTIS PASTEUR LIMITED
J07BF02
POLIOMYELITIS ORAL, TRIVALENT, LIVE ATTENUATED
1000000UNIT; 100000UNIT; 300000UNIT
SUSPENSION
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 1000000UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 100000UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 300000UNIT
ORAL
1/10/20/50DOSES
Schedule D
VACCINES
Active ingredient group (AIG) number: 0319633002; AHFS:
CANCELLED POST MARKET
2000-04-06